Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma

NCT05954780 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Selinexor

Sponsor

iOMEDICO AG

Collaborators

[object Object]
[object Object]